|
Unaudited Condensed Consolidated Statements of Income (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Dec. 28, 2014
|
Dec. 29, 2013
|
Dec. 28, 2014
|
Dec. 29, 2013
|
|
| Net sales | $ 23,743us-gaap_SalesRevenueGoodsNet | $ 20,619us-gaap_SalesRevenueGoodsNet | $ 59,888us-gaap_SalesRevenueGoodsNet | $ 57,283us-gaap_SalesRevenueGoodsNet |
| Cost of products sold | 17,115us-gaap_CostOfGoodsSold | 14,665us-gaap_CostOfGoodsSold | 43,132us-gaap_CostOfGoodsSold | 41,108us-gaap_CostOfGoodsSold |
| Gross profit | 6,628us-gaap_GrossProfit | 5,954us-gaap_GrossProfit | 16,756us-gaap_GrossProfit | 16,175us-gaap_GrossProfit |
| Legal expense | 59us-gaap_LegalFees | 144us-gaap_LegalFees | 1,360us-gaap_LegalFees | 701us-gaap_LegalFees |
| Other Marketing and administrative expenses | 3,297us-gaap_OtherSellingGeneralAndAdministrativeExpense | 2,951us-gaap_OtherSellingGeneralAndAdministrativeExpense | 9,665us-gaap_OtherSellingGeneralAndAdministrativeExpense | 9,446us-gaap_OtherSellingGeneralAndAdministrativeExpense |
| Income from operations | 3,272us-gaap_OperatingIncomeLoss | 2,859us-gaap_OperatingIncomeLoss | 5,731us-gaap_OperatingIncomeLoss | 6,028us-gaap_OperatingIncomeLoss |
| Other income (expense): | ||||
| Interest expense | (10)us-gaap_InterestExpense | (8)us-gaap_InterestExpense | (27)us-gaap_InterestExpense | (38)us-gaap_InterestExpense |
| Interest income | 1us-gaap_InvestmentIncomeInterest | 5us-gaap_InvestmentIncomeInterest | 17us-gaap_InvestmentIncomeInterest | 18us-gaap_InvestmentIncomeInterest |
| Other - net | (21)us-gaap_OtherNonoperatingIncomeExpense | 13us-gaap_OtherNonoperatingIncomeExpense | (31)us-gaap_OtherNonoperatingIncomeExpense | (2)us-gaap_OtherNonoperatingIncomeExpense |
| Income before income tax expense | 3,242us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | 2,869us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | 5,690us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | 6,006us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
| Income tax expense | 1,196us-gaap_IncomeTaxExpenseBenefit | 1,090us-gaap_IncomeTaxExpenseBenefit | 2,111us-gaap_IncomeTaxExpenseBenefit | 2,263us-gaap_IncomeTaxExpenseBenefit |
| Net income | $ 2,046us-gaap_NetIncomeLoss | $ 1,779us-gaap_NetIncomeLoss | $ 3,579us-gaap_NetIncomeLoss | $ 3,743us-gaap_NetIncomeLoss |
| Weighted average shares outstanding: | ||||
| Basic (in shares) | 10,072us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 9,859us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 10,041us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 9,845us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
| Effect of dilutive securities (in shares) | 30us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment | 18us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment | 35us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment | 13us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment |
| Diluted (in shares) | 10,102us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 9,877us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 10,076us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 9,858us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
| Earnings per share: | ||||
| Basic (in dollars per share) | $ 0.20us-gaap_EarningsPerShareBasic | $ 0.18us-gaap_EarningsPerShareBasic | $ 0.36us-gaap_EarningsPerShareBasic | $ 0.38us-gaap_EarningsPerShareBasic |
| Diluted (in dollars per share) | $ 0.20us-gaap_EarningsPerShareDiluted | $ 0.18us-gaap_EarningsPerShareDiluted | $ 0.36us-gaap_EarningsPerShareDiluted | $ 0.38us-gaap_EarningsPerShareDiluted |
| Cash dividends declared per share (in dollars per share) | $ 0.08us-gaap_CommonStockDividendsPerShareDeclared | $ 0.08us-gaap_CommonStockDividendsPerShareDeclared | $ 0.24us-gaap_CommonStockDividendsPerShareDeclared | $ 0.24us-gaap_CommonStockDividendsPerShareDeclared |
| X | ||||||||||
|
- Definition
Aggregate dividends declared during the period for each share of common stock outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Other generally recurring costs associated with normal operations excluding those directly related to the marketing or selling of products and services not otherwise defined. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|